source
- FDA, AstraZeneca prep for oncology adcommThe FDA is set to convene its first advisory meeting of oncology experts in about nine months, with a couple of AstraZeneca drugs as the focus of the discussion. Details about the meeting of the ...Endpoints · 3mo ago↗ source
- STAT+: Why conversations around health AI may be evolving beyond hypeIn this edition of AI Prognosis, Brittany Trang argues that the tide may be turning when it comes to how the health care industry talks about AI.STAT · 3mo ago↗ source
- Bristol Myers reaches a crossroads as a make-or-break year takes shapeBristol Myers Squibb is facing a bit of an identity crisis. CEO Chris Boerner is nearly two and a half years into his tenure, with most of his time defined byEndpoints · 3mo ago↗ source